Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of April 2025. The report, dated April 11, 2025, discloses a specific transaction in the company's own shares under its share buyback programme announced on March 28, 2025.
Key Financial Metrics and Transaction Details
The filing details a share repurchase executed on April 10, 2025. The transaction metrics are as follows:
- Shares Purchased: 902,692 ordinary shares
- Purpose: Cancellation under the Buyback Programme
- Highest Price Paid: 369.40 pence per share
- Lowest Price Paid: 363.00 pence per share
- Volume Weighted Average Price: 366.64 pence per share
Following this transaction, the company's registered share capital stands at 9,031,310,069 ordinary shares of £0.01 each. Of these, 4,080,205 are held as treasury shares, resulting in 9,027,229,864 ordinary shares with voting rights.
Material Changes
The primary material change reported is the reduction in the number of outstanding shares with voting rights due to the cancellation of the repurchased shares. The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity for the period.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on financial performance, or discussion of risks and contingencies beyond the standard disclosure regarding the share transaction. It notes that a full breakdown of individual trades is available via the London Stock Exchange and the company's investor website.
Key Facts for Investor Verification
- Verify the total number of shares with voting rights (9,027,229,864) for compliance with disclosure thresholds under FCA rules.
- Confirm the remaining capacity of the share buyback programme announced on March 28, 2025.
- Review the full trade breakdown at the provided RNS link for granular execution details.
- Note that this filing does not contain financial performance results; refer to the most recent Form 20-F or quarterly reports for revenue and profit data.